These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26156209)

  • 21. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.
    Pickering BS; Hardham JM; Smith G; Weingartl ET; Dominowski PJ; Foss DL; Mwangi D; Broder CC; Roth JA; Weingartl HM
    Vaccine; 2016 Sep; 34(40):4777-86. PubMed ID: 27544586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoinformatics Approach for Epitope-Based Peptide Vaccine Design and Active Site Prediction against Polyprotein of Emerging Oropouche Virus.
    Adhikari UK; Tayebi M; Rahman MM
    J Immunol Res; 2018; 2018():6718083. PubMed ID: 30402510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody prophylaxis and therapy against Nipah virus infection in hamsters.
    Guillaume V; Contamin H; Loth P; Grosjean I; Courbot MC; Deubel V; Buckland R; Wild TF
    J Virol; 2006 Feb; 80(4):1972-8. PubMed ID: 16439553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on the DNA immunogenicity of fusion and attachment glycoproteins of Nipah virus].
    Wang XJ; Ge JY; Wang QH; Hu S; Lin XM; Bu ZG
    Bing Du Xue Bao; 2008 Jan; 24(1):47-52. PubMed ID: 18320822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel innate immune functions for galectin-1: galectin-1 inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokines.
    Levroney EL; Aguilar HC; Fulcher JA; Kohatsu L; Pace KE; Pang M; Gurney KB; Baum LG; Lee B
    J Immunol; 2005 Jul; 175(1):413-20. PubMed ID: 15972675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs.
    Kong D; Wen Z; Su H; Ge J; Chen W; Wang X; Wu C; Yang C; Chen H; Bu Z
    Virology; 2012 Oct; 432(2):327-35. PubMed ID: 22726244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia Virus MVA Activates Specific CD8 and CD4 T Cells in Mice.
    Kalodimou G; Veit S; Jany S; Kalinke U; Broder CC; Sutter G; Volz A
    Viruses; 2019 Dec; 12(1):. PubMed ID: 31878180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins.
    Dang HV; Cross RW; Borisevich V; Bornholdt ZA; West BR; Chan YP; Mire CE; Da Silva SC; Dimitrov AS; Yan L; Amaya M; Navaratnarajah CK; Zeitlin L; Geisbert TW; Broder CC; Veesler D
    Nat Struct Mol Biol; 2021 May; 28(5):426-434. PubMed ID: 33927387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine.
    Loomis RJ; DiPiazza AT; Falcone S; Ruckwardt TJ; Morabito KM; Abiona OM; Chang LA; Caringal RT; Presnyak V; Narayanan E; Tsybovsky Y; Nair D; Hutchinson GB; Stewart-Jones GBE; Kueltzo LA; Himansu S; Mascola JR; Carfi A; Graham BS
    Front Immunol; 2021; 12():772864. PubMed ID: 34956199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A computational approach for identification of epitopes in dengue virus envelope protein: a step towards designing a universal dengue vaccine targeting endemic regions.
    Chakraborty S; Chakravorty R; Ahmed M; Rahman A; Waise TM; Hassan F; Rahman M; Shamsuzzaman S
    In Silico Biol; 2010; 10(5-6):235-46. PubMed ID: 22430357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characteristics of the Nipah virus glycoproteins.
    Diederich S; Maisner A
    Ann N Y Acad Sci; 2007 Apr; 1102():39-50. PubMed ID: 17470910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complementing defective viruses that express separate paramyxovirus glycoproteins provide a new vaccine vector approach.
    Chattopadhyay A; Rose JK
    J Virol; 2011 Mar; 85(5):2004-11. PubMed ID: 21177820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein.
    Alam A; Ali S; Ahamad S; Malik MZ; Ishrat R
    Immunology; 2016 Dec; 149(4):386-399. PubMed ID: 27485738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of Epitope-Based Peptide Vaccine Against the Chikungunya Virus by Immuno-informatics Approach.
    Anwar S; Mourosi JT; Khan MF; Hosen MJ
    Curr Pharm Biotechnol; 2020; 21(4):325-340. PubMed ID: 31721709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A common conserved peptide harboring predicted T and B cell epitopes in domain III of envelope protein of Japanese Encephalitis Virus and West Nile Virus for potential use in epitope based vaccines.
    Slathia PS; Sharma P
    Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():238-245. PubMed ID: 31300121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple Strategies Reveal a Bidentate Interaction between the Nipah Virus Attachment and Fusion Glycoproteins.
    Stone JA; Vemulapati BM; Bradel-Tretheway B; Aguilar HC
    J Virol; 2016 Dec; 90(23):10762-10773. PubMed ID: 27654290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters.
    Lo MK; Bird BH; Chattopadhyay A; Drew CP; Martin BE; Coleman JD; Rose JK; Nichol ST; Spiropoulou CF
    Antiviral Res; 2014 Jan; 101():26-9. PubMed ID: 24184127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.
    Mire CE; Versteeg KM; Cross RW; Agans KN; Fenton KA; Whitt MA; Geisbert TW
    Virol J; 2013 Dec; 10():353. PubMed ID: 24330654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant nipah virus vaccines protect pigs against challenge.
    Weingartl HM; Berhane Y; Caswell JL; Loosmore S; Audonnet JC; Roth JA; Czub M
    J Virol; 2006 Aug; 80(16):7929-38. PubMed ID: 16873250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization strategies against henipaviruses.
    Broder CC; Geisbert TW; Xu K; Nikolov DB; Wang LF; Middleton D; Pallister J; Bossart KN
    Curr Top Microbiol Immunol; 2012; 359():197-223. PubMed ID: 22481140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.